1. Home
  2. EXEL
  3. EXEL News

Latest Exelixis Inc. (EXEL) News on September 8, 2025

Is Exelixis Still Attractive After Recent 13% Pullback and Strong Cash Flow Growth?

Simply Wall St.

17 days ago

Is Exelixis Still Attractive After Recent 13% Pullback and Strong Cash Flow Growth?

Kymera Therapeutics Stock Earns 92 RS Rating

Investor's Business Daily

3 months ago

Kymera Therapeutics Stock Earns 92 RS Rating

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Exelixis Inc Earnings Call

Share on Social Networks: